SCHEMBL3630941

SCHEMBL3630941

CC(C)(C)OC(=O)NC1CNc2ccccc2-c2c(C3CCCCC3)c3ccc(C(=O)O)cc3n2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.49
MMP12 P39900 1/20 0.49
EPHX2 P34913 1/20 0.44
SCN9A Q15858 3/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NR1I2 O75469 4/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
AKT1 P31749 1/20 0.35
RORC P51449 1/20 0.35
NPC1L1 Q9UHC9 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
OGFRL1 Q5TC84 1/20 0.34
KDM1A O60341 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3578124 0.88 PRKCA (0.47) PRKCAMMP12EPHX2SCN9ANR1I2
SCHEMBL3942843 0.87 PRKCA (0.51) PRKCAMMP12EPHX2SCN9AKMT2A
SCHEMBL2960110 0.85 PRKCA (0.63) PRKCAMMP12SCN9AKMT2AL3MBTL1
SCHEMBL3664850 0.82 PRKCA (0.40) PRKCAMMP12EPHX2SCN9ANR1I2
SCHEMBL14253355 0.81 PRKCA (0.53) PRKCAMMP12SCN9ANR1I2CYP3A4
SCHEMBL13940288 0.81 PRKCA (0.44) PRKCAMMP12EPHX2SCN9AKMT2A
SCHEMBL3940946 0.80 PRKCA (0.44) PRKCAMMP12SCN9ANR1I2CYP3A4
SCHEMBL393732 0.79 PRKCA (0.55) PRKCAMMP12SCN9AKMT2AL3MBTL1
SCHEMBL3814277 0.79 PRKCA (0.48) PRKCAMMP12KMT2AL3MBTL1NR1I2
SCHEMBL14253452 0.78 PRKCA (0.54) PRKCAMMP12SCN9ANR1I2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662809-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-02-16 US disclosed
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, HAVCR2 PRKCA 4232/4885MMP12 2495/4885EPHX2 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.